Content by Tecan

Technological advances help scientists detect genome-wide DNA methylation and hydroxymethylation levels in parallel.

Immunoassays that measure neopterin in patient samples provide a wealth of information that is useful in the laboratory and the clinic.

Streamlining and automating cell-based assays for measuring intracellular calcium.

Big discoveries come from miniaturized assays

The CRISPR-Cas system, supported by advances in plate reader technology, has transformed drug discovery processes.

One sophisticated laboratory tool detects absorbance, fluorescence, FRET, luminescence, live cells, and more, facilitating a wide variety of experimental findings.

An integrated system rapidly measures DNA and RNA without sample loss.

Scientists use ELISAs to assess the immunity and etiology of immune responses to coronavirus during the COVID-19 pandemic.

Cammie Lesser will discuss how she turns a probiotic into a drug-delivering machine, while Andrew Y. Koh will describe the connection between the gut microbiota and cancer immunotherapy efficacy.

Tecan has become one of the first companies to meet the requirements of the European Union’s In Vitro Diagnostic Regulation (IVDR) 2017/746 (Annex IX, Chapter I and III), successfully completing certification of its IBL International DHEA Saliva ELISA diagnostic assay kit through BSI Notified Body 2797.

Tecan today announces the launch of NGS DreamPrep™, a fully-automated approach to next-generation sequencing (NGS) library preparation for research use. This groundbreaking new approach offers quality controlled, sequencing-ready NGS libraries in just a matter of hours, with minimal manual interaction and no sample loss.

A fully automated affinity purification solution

“Fast liquid transfer down to picoliter levels with Tecan’s D300e”

The Fluent™ Laboratory Automation Solution offers greater throughput and flexibility for compound management workflows.